Gain Therapeutics Inc. (GANX)
NASDAQ: GANX
· Real-Time Price · USD
1.72
0.03 (1.78%)
At close: Aug 20, 2025, 2:11 PM
Gain Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for GANX stock have an median target of 6.5, with a low estimate of 6 and a high estimate of 8. The median target predicts an increase of 277.91% from the current stock price of 1.72.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 6 | 6.75 | 6.5 | 8 |
| Change | 248.84% | 292.44% | 277.91% | 365.12% |
Latest Analyst Insight Report
HC Wainwright & Co. maintains a Buy rating on Gain... Unlock content with Pro Subscription
Updated Jul 03, 2025
| Rating | Nov 24 | Dec 24 | Mar 25 | May 25 | Jul 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 2 | 3 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 3 | 1 | 1 | 1 |
Financial Forecast this Year
Revenue This Year
40K
from 0
Increased by n/a%
Revenue Next Year
50K
from 40K
Increased by 25.0%
EPS This Year
-0.61
from -0.89
Increased by 31.5%
EPS Next Year
-0.71
from -0.61
Increased by -16.4%